In this episode, Michelle discusses AI2's Olmo 2 1B, a model that surpasses offerings from major tech companies, and its significance for the AI community. She highlights how AI is transforming medicine through genome sequencing at the Australian National University, showcasing its potential to revolutionize healthcare. The episode also examines an AI tool that speeds up building permit processes for wildfire victims in Los Angeles, underscoring AI's practical benefits in crisis response. Michelle delves into OpenAI's recent restructuring, exploring its implications and future impact on the industry. The episode concludes with closing remarks and a reminder about subscriptions.

(0:00) AI2's Olmo 2 1B outperforms tech giants and its impact on AI community

(2:43) AI revolutionizing medicine with genome sequencing at Australian National University

(5:10) AI tool accelerates building permits for wildfire victims in Los Angeles

(8:29) OpenAI's restructuring: implications, concerns, and future impact

(11:21) Closing remarks and subscription reminder